等待开盘 05-18 09:30:00 美东时间
0.000
0.00%
Sinovac Biotech (NASDAQ:SVA) reported quarterly earnings of $0.06 per share. This is a 94.92 percent decrease over earnings of $1.18 per share from the same period last year. The company reported $130.270 million in
05-09 05:08
The latest update is out from Sinovac Biotech ( ($SVA) ). On November 18, 2025,...
01-31 04:47
wumiancaijing.com / 科兴生物内斗十年,上市地位差点不保,狂赚近千亿后陷入沉寂,控制权争夺何时能结束? 重要提醒!!!为防失联,请“星...
01-29 16:34
BRIEF-Sinovac Announces Nasdaq Hearings Panel Grants Continued Listing Jan 22 (Reuters) - Sinovac Biotech Ltd SVA.O : SINOVAC ANNOUNCES NASDAQ HEARINGS PANEL GRANTS CONTINUED LISTING Source text: ID:nBw4Dbpsla Further company coverage: SVA.O (( Reuters.Briefs@thomsonreuters.com ;))
01-22 19:07
1月4日,据科兴生物(SVA.US)官微消息,智利政府2026年度流感疫苗全球招标结果于近日揭晓,科兴再度成为独家供应商,签约订单超800万剂。首批疫苗将于2...
01-04 15:46
Sinovac Biotech Ltd. (NASDAQ:SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Antigua High Court has ordered that the directors Mr. Simon Anderson, Mr.
2025-12-17 20:05